Skip to content
Advertisement

FILE - The Biogen Inc., headquarters is pictured on March 11, 2020, in Cambridge, Mass. Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple of years ago. The drugmaker said Wednesday, Jan. 31, 2024 that it will end a study of the drug needed for full approval from the Food and Drug Administration, and it will stop sales of the drug.(AP Photo/Steven Senne, File)

FILE - The Biogen Inc., headquarters is pictured on March 11, 2020, in Cambridge, Mass. Biogen will stop developing its Alzheimer’s treatment Aduhelm, a drug once seen as a potential blockbuster before stumbling soon after its launch a couple of years ago. The drugmaker said Wednesday, Jan. 31, 2024 that it will end a study of the drug needed for full approval from the Food and Drug Administration, and it will stop sales of the drug.(AP Photo/Steven Senne, File)

Featured Photo Galleries

01-Army parade.png

Military parade celebrates Army’s 250th

Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.

20250330 Sabatini-Caps-Sabres 001.jpg

Ovi scores goal 890, Caps lose to Sabres 8-5

Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)